The phrase "agreement for testing" is correct and usable in written English.
It can be used in contexts where parties are formalizing terms related to testing, such as in product development or research agreements.
Example: "Before we proceed with the trial phase, we need to finalize the agreement for testing to ensure all parties are aligned."
Alternatives: "testing agreement" or "testing contract".
Applying inter-rater agreement statistics for testing the strength of agreement between two classifications, Cohen's kappa values above 0.8 on ethN and formN were obtained (κ = 0.955, 95% CI: 0.944 to 0.965; κ = 0.929, 95% CI: 0.895 to 0.964; respectively).
The current collective-bargaining agreement calls for testing only in preseason physicals or when a team doctor has reason to suspect a player is using drugs.
It has been found that the analysis results obtained using the DM and LM approaches are in close agreement for test problems studied.
* = log transformed Bland-Altman plots indicated that most points lie within the 95% limits of agreement for test-retest measurements.
In separate validation and reliability studies, the questionnaire has shown substantial agreement for test-retest reliability and from low to substantial agreement for criterion validity [ 23, 24].
However, the 2011 agreement called for testing only in spring training and the off-season, reflecting concerns by the players about how their blood would be collected before or after regular-season games and whether the process would impact their performance on the field.
This finding is consistent with another report showing substantial differences in the rates of partner notification discussions compared to the actual agreement for HIV testing.
However, several studies have found that there was only fair to moderate agreement for Ki67 testing between CNB and SRS, and that the κ value was much lower than ER, PR, and HER2 evaluation; this was mainly interpreted as sampling error or tumor heterogeneity [ 11, 12].
Historically, the VA has reserved the right to deny patients pain medicine if they violate the terms of their Opioid Pain Care Agreement by testing positive for marijuana.
